Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3928/0147-7447-19930301-15 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review.
Diagnostics (Basel)
December 2024
Orthopedic Surgery, Macquarie University Hospital, Sydney, NSW 2113, Australia.
: Giant cell tumor of bone (GCTB) is a locally aggressive tumor. It accounts for only 5% of all bony tumors. Early diagnosis, and follow-up for recurrence is often difficult due to a lack of biogenetic markers.
View Article and Find Full Text PDFCommon Benign Bone Lesions and Return to Sports: A Case Report and Scoping Review.
Am J Sports Med
January 2025
University of Alabama at Birmingham, Birmingham, Alabama, USA.
Background: Benign bone lesions are a common incidental finding in athletes during workup for musculoskeletal complaints, and athletes are frequently advised to halt participation in contact sports. There are no current guidelines to assist clinicians in referring patients with these lesions to a subspecialist or in advising athletes on the safety of returning to sport.
Purpose: To assist sports medicine physicians in appropriate referral for patients with benign bone lesions through presentation of a literature review and the case of an adolescent athlete with a benign bone lesion in a location with a significant fracture risk.
A rare case of soft tissue chondroblastoma of the quadratus femoris muscle: A case report and literature review.
Radiol Case Rep
February 2025
Faculty of Medicine and Pharmacy, Mohammed 1st University, Oujda, Morocco.
Chondroblastomas are very rare benign primary bone tumors that typically develop in bones in young adults. Extraosseous chondroblastomas are extremely rare, with a few case reports documented in the literature. The treatment is surgical with a high healing rate.
View Article and Find Full Text PDFFive-year experience with titanium mesh for rigid chest wall reconstruction.
JTCVS Tech
December 2024
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.
Objective: To characterize the performance of titanium mesh (TM) (off-label) for rigid chest wall reconstruction at a single institution over a 5-year period.
Methods: Between January 1, 2019, and May 15, 2023, 22 patients (median age, 61 years) underwent chest wall resection with TM reconstruction at Cleveland Clinic. Indications for resection included sarcoma (n = 15), breast cancer (n = 2), lung cancer (n = 2), chondroblastoma (n = 1), and benign neoplasm (n = 2).
Chondroblastoma of the femoral head: curettage without dislocation.
BMC Surg
November 2024
Department of Orthopedics Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders; Chongqing Key Laboratory of Structural Birth Defect and Reconstruction, Chongqing, China.
Article Synopsis
- * This study involved 6 children with femoral head CBL who underwent curettage, anhydrous alcohol application, and bone grafting, with outcomes measured using MSTS scores and the Lodwick classification for bone destruction.
- * Results showed varying statuses of the epiphyseal plate, a mean MSTS score of 28, and one incident of a femoral neck fracture post-surgery, indicating that this technique is an effective treatment option for CBL in this difficult location.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!